Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion type Assertion NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_head.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion evidence source_evidence_literature NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion SIO_000772 19420352 NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion wasDerivedFrom gad-20150221 NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.
- NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_assertion wasGeneratedBy ECO_0000203 NP146703.RAOH-298AhzX95WvxKGUobrhOI-QydYn83xhg2-UpMgmU130_provenance.